News
NVOS
--
0.00%
--
Novo Integrated Sciences GAAP EPS of -$0.07, revenue of $3.16M
Novo Integrated Sciences press release (NASDAQ:NVOS): Q1 GAAP EPS of -$0.07. Revenue of $3.16M (+46.3% Y/Y). Shares +8.76%.
Seekingalpha · 3d ago
Novo Integrated Sciences Reports First Quarter Financial Results
BELLEVUE, Wash., January 18, 2022--Novo Integrated Sciences Reports First Quarter Financial Results
Business Wire · 3d ago
Novo Integrated Sciences signs amended master facility agreement with LA Fitness
Novo Integrated Sciences (NASDAQ:NVOS) has slumped 4.23% pre-market after announcing signing of an amended and restated Master Facility License Agreement with LAF Canada Company (doing business as LA Fitness). Novo originally signed
Seekingalpha · 01/14 13:18
BRIEF-Novo Integrated Sciences Announces Signing Of A Master Facility License Agreement With LA Fitness In Canada
reuters.com · 01/14 13:13
Novo Integrated Sciences Reports Master Facility License Deal With LA Fitness In Canada, No Terms Disclosed
Novo Integrated Sciences, Inc. (NASDAQ:NVOS) (the “Company” or “Novo”) today is announcing the signing of an Amended and Restated Master Facility License Agreement (“MFLA”) with LAF
Benzinga · 01/14 13:04
Novo Integrated Sciences Announces the Signing of a Master Facility License Agreement with LA Fitness in Canada
BELLEVUE, Wash., January 14, 2022--Novo Integrated Sciences Announces Signing of a Master Facility License Agreement with LA Fitness in Canada
Business Wire · 01/14 13:00
Novo Integrated Sciences Reports Was Granted Natural Product Number By Health Canada For IoNovo Iodine Branded Product
Novo Integrated Sciences, Inc. (NASDAQ:NVOS) (the “Company” or “Novo”), pioneering a holistic approach to patient-first health and wellness through a multidisciplinary healthcare ecosystem of
Benzinga · 12/23/2021 13:02
Novo Integrated Sciences Granted Natural Product Number (NPN) by Health Canada for IoNovo Iodine Branded Product
BELLEVUE, Wash., December 23, 2021--Novo Integrated Sciences Granted Natural Product Number (NPN) by Health Canada for IoNovo Iodine Branded Product
Business Wire · 12/23/2021 13:00
Novo Integrated Sciences reports FY results
Novo Integrated Sciences (NASDAQ:NVOS): FY GAAP EPS of -$0.18. Revenue of $9.31M (+18.4% Y/Y) Press Release
Seekingalpha · 12/15/2021 09:22
Novo Integrated gains 8% after acquiring majority stake in Terragenx
Novo Integrated Sciences (NASDAQ:NVOS) has acquired 91% of Terragenx and the intellectual property portfolio for the unique formulation and manufacturing capability to produce a water-soluble iodine micro-nutrient that is FDA
Seekingalpha · 11/30/2021 14:26
BRIEF-Novo Integrated Sciences Acquires Majority Stake In Terragenx And Intellectual Property For FDA And Health Canada Approved Water-Soluble Iodine Micro-Nutrient
reuters.com · 11/30/2021 13:28
Novo Integrated Sciences Acquires 91% Majority Stake In Terragenx At $3.35/Share
Iodine, an essential nutrient, when in aerosolized aqueous form can be safely ingested to kill bacteria and deactivate various viruses Novo Integrated Sciences, Inc. (NASDAQ:NVOS) (the "Company" or
Benzinga · 11/30/2021 13:02
BRIEF-Novo Integrated Sciences Inc Subsidiary, Novo Healthnet Limited, And EK-Tech Solutions Announce Joint Venture For Enhanced Telehealth Platform
reuters.com · 10/14/2021 12:14
Novo Integrated Sciences’ subsidiary, Novo Healthnet Limited, and EK-Tech Solutions Announce Joint Venture for Enhanced Telehealth Platform
BELLEVUE, Wash., October 14, 2021--Novo Integrated Sciences' subsidiary, Novo Healthnet Limited, and EK-Tech Solutions Announce Joint Venture for Enhanced Telehealth Platform
Business Wire · 10/14/2021 12:00
Novo Integrated Sciences Signs LOIs to Acquire 7 Pharmacies in the US
Image provided by Tbel Abuseridze on Unsplash
Benzinga · 10/13/2021 12:56
22 Stocks Moving in Friday's Pre-Market Session
Gainers Focus Universal Inc. (NASDAQ: FCUV) rose 42% to $15.24 in pre-market trading. The company’s shares jumped around 65% over the previous month.
Benzinga · 09/24/2021 10:49
Novo Integrated Sciences Agrees to Buy Seven Pharmacies in the US
MT Newswires · 08/30/2021 09:08
Novo Integrated Sciences' Subsidiary, Acenzia, Signs Exclusive Licensing Agreement With Performance Inspired Nutrition To Manufacture And Distribute In The Middle East
Co-Founded by multiple time Oscar-award nominee, Mark Wahlberg, and retail health and wellness executive, Tom Dowd, PI Nutrition offers honest, all-natural, and clean health and wellness products PI Nutrition products
Benzinga · 08/18/2021 12:04
Novo Integrated Sciences’ Subsidiary, Acenzia, Signs Exclusive Licensing Agreement with Performance Inspired Nutrition to Manufacture and Distribute in the Middle East
BELLEVUE, Wash., August 18, 2021--Co-Founded by Mark Wahlberg and industry executive, Tom Dowd, PI Nutrition completes a licensing agreement with Aceniza, Inc. (an NVOS subsidiary).
Business Wire · 08/18/2021 12:00
Novo Integrated Sciences Unit to Distribute Nutritional Products, Natural Supplements in the Middle East
MT Newswires · 08/18/2021 09:41
Webull provides a variety of real-time NVOS stock news. You can receive the latest news about Novo Integrated through multiple platforms. This information may help you make smarter investment decisions.
About NVOS
Novo Integrated Sciences, Inc. is a parent company to subsidiaries throughout North America. The Company owns Canadian and United States subsidiaries, which provide essential and differentiated solutions to the delivery of multidisciplinary primary care and related wellness products through the integration of medical technology, interconnectivity, advanced therapeutics, personalized product offerings, and rehabilitative science. Its Canadian subsidiary, Novo Healthnet Limited, provides its services and products through both clinic and eldercare related operations. The Company has two reportable segments: healthcare services, and product manufacturing and development. Its primary care services include physiotherapy, chiropractic care, occupational therapy, eldercare, acupuncture and functional dry needling, chiropody, stroke and traumatic brain injury, kinesiology, vestibular therapy, concussion management, sports medicine therapy and baseline testing and women’s pelvic health programs.